Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geneyus is an Australian precision medicine company specializing in pharmacogenomics (PGx) to optimize medication management. The company provides genomic testing services and digital clinical decision support tools that help healthcare providers tailor drug prescriptions based on a patient's genetic profile. By focusing on therapeutic areas such as mental health, cardiology, and pain management, Geneyus aims to reduce adverse drug reactions and improve treatment efficacy. Their platform integrates genetic data into clinical workflows, facilitating personalized healthcare at scale. The company's mission is to ensure patients receive the right medication at the right dose from the start.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Geneyus.